Fameglow Holdings Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG3313G1038
HKD
6.64
5.34 (410.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROCE of 33.03%

 
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

Healthy long term growth as Net Sales has grown by an annual rate of 50.28%

 
4

The company has declared Positive results for the last 4 consecutive quarters

5

With ROE of 43.10%, it has a Expensive valuation with a 12.29 Price to Book Value

6

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 3,840 Million ()

stock-summary
P/E

29.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.39

stock-summary
Return on Equity

39.50%

stock-summary
Price to Book

30.25

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
730.0%
0%
730.0%
6 Months
876.47%
0%
876.47%
1 Year
1797.14%
0%
1797.14%
2 Years
1343.48%
0%
1343.48%
3 Years
2229.82%
0%
2229.82%
4 Years
3305.13%
0%
3305.13%
5 Years
2113.33%
0%
2113.33%

Fameglow Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
50.28%
EBIT Growth (5y)
26.55%
EBIT to Interest (avg)
3.78
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
3.36
Tax Ratio
16.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
33.03%
ROE (avg)
36.57%

Valuation key factors

Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
12.29
EV to EBIT
24.31
EV to EBITDA
11.54
EV to Capital Employed
11.45
EV to Sales
3.02
PEG Ratio
2.25
Dividend Yield
NA
ROCE (Latest)
47.10%
ROE (Latest)
43.10%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Fameglow Holdings Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2023 is 26.73% vs 118.76% in Mar 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2023 is 286.36% vs 67.41% in Mar 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'23",
        "Mar'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "227.60",
          "val2": "179.60",
          "chgp": "26.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "64.30",
          "val2": "34.80",
          "chgp": "84.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.80",
          "val2": "4.90",
          "chgp": "-22.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.00",
          "val2": "3.30",
          "chgp": "-39.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.40",
          "val2": "-8.80",
          "chgp": "286.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "76.80%",
          "val2": "-46.80%",
          "chgp": "12.36%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Mar'23stock-summary

Mar'23
Mar'22
Change(%)
Net Sales
227.60
179.60
26.73%
Operating Profit (PBDIT) excl Other Income
64.30
34.80
84.77%
Interest
3.80
4.90
-22.45%
Exceptional Items
2.00
3.30
-39.39%
Consolidate Net Profit
16.40
-8.80
286.36%
Operating Profit Margin (Excl OI)
76.80%
-46.80%
12.36%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2023 is 26.73% vs 118.76% in Mar 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2023 is 286.36% vs 67.41% in Mar 2022

stock-summaryCompany CV
About Fameglow Holdings Ltd. stock-summary
stock-summary
Fameglow Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available